Log In
BCIQ
Print this Print this
 

IPS-02001

  Manage Alerts
Collapse Summary General Information
Company InnoPharmaScreen Inc.
DescriptionOsteoporosis inhibitor
Molecular Target Integrin alpha(5)beta(3) (CD49e/CD61) ; Osteopontin (Opn) (Spp1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today